This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sansom, O. J. Articles by Clarke, A. R. Search for Related Content PubMed PubMed Citation Articles by Sansom, O. J. Articles by Clarke, A. R.

Suppression of Intestinal and Mammary Neoplasia by Lifetime Administration of Aspirin in Apc^Min/+ and Apc^Min/+, Msh2^-/- Mice¹

Cardiff School of Biosciences, Cardiff University, Cardiff CF10 3US, United Kingdom [O. J. S., A. R. C.]; Department of Pathology [O. J. S.], University of Edinburgh, Edinburgh EH8 9AG, Scotland; and Colon Cancer Genetics Group, Department of Oncology, MRC Human Genetics Unit, Western General Hospital, Edinburgh, EH4 2XU [L. A. S., M. G. D.]

Numerous studies have indicated that exposure to nonsteroidal anti-inflammatory drugs is associated with a lowered risk of colorectal cancer. However, analyses of the effect of aspirin upon tumorigenesis in Apc^Min/+ mice have yielded contrasting results. We show that adult dietary exposure to aspirin does not suppress intestinal tumorigenesis in Apc^Min/+ mice, but that continual exposure from the point of conception does. To test whether this regime could suppress the phenotype of murine models of hereditary nonpolyposis colorectal cancer, Msh2-deficient mice were exposed to aspirin. This did not modify the mutator phenotype of Msh2^-/- mice, but weakly extended survival. Finally, we analyzed (Apc^Min/+, Msh2^-/-) mice and found that lifetime aspirin exposure significantly delayed the onset of both intestinal and mammary neoplasia. Thus embryonic and perinatal exposure to aspirin suppresses neoplasia specifically associated with the loss of Apc function, opening a potential window of opportunity for nonsteroidal anti-inflammatory drug intervention.

This article has been cited by other articles:

				M. Lu, A. Strohecker, F. Chen, T. Kwan, J. Bosman, V. C. Jordan, and V. L. Cryns Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels Clin. Cancer Res., May 15, 2008; 14(10): 3168 - 3176. [Abstract] [Full Text] [PDF]

				M. V. Williams, S. H. Lee, M. Pollack, and I. A. Blair Endogenous Lipid Hydroperoxide-mediated DNA-adduct Formation in Min Mice J. Biol. Chem., April 14, 2006; 281(15): 10127 - 10133. [Abstract] [Full Text] [PDF]

				D. E. Corpet and F. Pierre Point: From Animal Models to Prevention of Colon Cancer. Systematic Review of Chemoprevention in Min Mice and Choice of the Model System Cancer Epidemiol. Biomarkers Prev., May 1, 2003; 12(5): 391 - 400. [Abstract] [Full Text] [PDF]

				H. J. Lin, K. M. Lakkides, T. O. Keku, S. T. Reddy, A. D. Louie, I. H. Kau, H. Zhou, J. S. Y. Gim, H. L. Ma, C. F. Matthies, et al. Prostaglandin H Synthase 2 Variant (Val511Ala) in African Americans May Reduce the Risk for Colorectal Neoplasia Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1305 - 1315. [Abstract] [Full Text] [PDF]